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The sudden infant death syndrome (SIDS)–critical diaphragm failure (CDF) hypothesis 
was first published by Siren and Siren in 2011 (1). Since its publication, the hypothesis 
has continued to generate interest and several colleagues have contributed perspectives 
and insights to it (2–5). The basic premise of the hypothesis is that the diaphragm is a vital 
organ that must continuously generate adequate force to maintain ventilation, and that 
CDF is a terminal event and the cause of death in SIDS. I have argued in two follow-up 
articles that all SIDS factors either increase the workload of the respiratory muscles, the 
diaphragm being the primary muscle affected, or reduce its force generating capacity (6, 
7). The SIDS–CDF hypothesis posits that SIDS has many contributing factors but only 
one cause, namely, the failure of the vital respiratory pump. There are several known 
SIDS factors, such as the prone sleeping position, non-lethal infections, deep sleep, 
gestational prematurity, low birth weight, cigarette smoke, male gender, and altitude, 
but of these, some such as the prone sleeping position more significantly both impact 
diaphragm function and correlate with SIDS. However, SIDS cases are multifactorial and 
as such can be caused by different combinations of factors. An infection combined with 
a prone sleeping position and elevated room temperature could lead to SIDS, whereas 
in other circumstances, low birth weight, cigarette smoke, prone sleeping position, and 
altitude could result in CDF and SIDS. The SIDS–CDF hypothesis also posits that SIDS 
does not have a congenital or genetic origin, and that efforts to identify significant genetic 
anomalies in SIDS victims are unlikely to be successful (8–11).
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This short review has two purposes. The first is to examine two SIDS risk factors in the context of 
the SIDS–CDF hypothesis that have not been addressed in previous articles, namely, magnesium 
deficiency and hyperthermia. Second, this review is an attempt to raise awareness of the research 
community to the possible role of the vital respiratory muscles in etiology of the syndrome. As I 
reiterated in a recent article, the possibility that SIDS is caused by critical weakness of the diaphragm 
has been largely ignored. It is telling that as of November 2016, out of approximately 11,000 SIDS 
articles in PubMed, only 50 articles contained the search words “SIDS and diaphragm,” and only 
a few of those actually address the role of the vital respiratory muscle in SIDS. At the end of the 
commentary, I will suggest avenues for future research.
In 1972, Joan Caddell advanced a hypothesis in The Lancet arguing that magnesium deficiency 
is the cause of death in SIDS (12). Between 1972 and 2001, Caddell and others attempted to provide 
experimental evidence between magnesium deficiency and SIDS, but the hypothesis remains neither 
proven nor disproven (13). Systemic magnesium levels are notoriously difficult to measure accurately, 
and studies on magnesium deficiency in SIDS victims are inconclusive (14, 15). A causal mechanism 
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was never established, although magnesium deficiency shock 
and compromised thermoregulation were proposed as possible 
culprits (16, 17). However, Caddell’s hypothesis prompted several 
interesting studies. She asserted that ethnic groups with low SIDS 
rates (at or below 1.2 per 1,000 live births) have rich dietary sources 
of magnesium, while those with SIDS rates exceeding 5.0 typically 
have magnesium poor diets (17), and while the evidence for this 
is circumstantial, there are two other population level studies 
that warrant our closer attention. Following the publication of 
Caddell’s hypothesis, Swift and Emery suggested that “the best 
way to test Caddell’s hypothesis would be to attempt a correlation 
of the incidence of unexpected death to areas where there is a 
deprivation of magnesium in the water-supply” (18). Two studies, 
conducted some 30 years apart in USA and Taiwan, do exactly 
that. Despite the different population base and geography, the 
studies reach strikingly similar conclusions about the relation-
ship between magnesium in municipal drinking water and the 
incidence of SIDS.
The first study was published in The Lancet in 1973 and 
was based on data from the California State Department of 
Public Health that provided ranges of magnesium and cal-
cium concentrations in county water supplies. The authors 
concluded that “the median maximum magnesium concentra-
tion is lower in counties with higher rates of S.U.D. [sudden 
unexpected infant death].” The authors note that the study has 
several limitations such as the counties having large ranges for 
magnesium and the strong negative correlation of magnesium 
and calcium concentrations to overall infant mortality (19). 
By itself, the study provides interesting but insufficient data to 
suggest that magnesium levels in municipal water affect SIDS 
rates.
However, a similar, but far more robust, study was con-
ducted in Taiwan in 2005, which reached similar conclusions. 
The study by Chiu and colleagues used data from the Taiwan 
Water Supply Corporation and mapped all SIDS death (501 
cases) from 1988 to 1997 to controls who died from other 
causes (20). The mean magnesium concentration in municipal 
water was 9.69  mg/l for SIDS cases and 11.46 for controls. 
The authors note: “the group with the highest magnesium 
levels (>14.1  mg/l) had an OR [odds ratio] which remained 
significantly less than 1.0 (0.70, 95% CI = 0.51–0.97). In addi-
tion, there was a significant trend toward a decreased SIDS 
risk with increasing magnesium levels in drinking water (X2 
for linear trend = 12.83, p < 0.05).” The authors conclude that 
there seems to be a significant protective effect of magnesium 
intake from drinking water against SIDS. They further observe 
that: “the fact that a significantly protective effect of magne-
sium intake via drinking water was found in the group with 
the highest levels of intake suggested that only subjects with 
magnesium intake via drinking water above a certain level 
receive a beneficial effect on their risk of SIDS.” The authors 
also address the question of how the relatively small intake on 
magnesium from drinking water can significantly affect the 
amount of magnesium in the body and point to research on 
magnesium absorption from drinking water that support this 
hypothesis (21). Any study of this nature has limitations, but 
due to the sophisticated health care and administrative system 
in Taiwan and the rigorous categorization of causes of death, 
the authors argue that these have been appropriately mitigated. 
The same research group has established correlations between 
magnesium levels in municipal water and the occurrence of 
various types of cancers, hypertension, and diabetes. No causal 
mechanism for the role of magnesium in SIDS is offered.
The studies by Chiu and his team and the earlier work by 
Godwin and Brown provide enough robust data to warrant an 
explanation, and I will address how the SIDS–CDF hypothesis 
would explain the data. The hypothesis posits that SIDS is caused 
by factors that either increase the respiratory workload of the 
diaphragm or decrease its force generating capacity. It is well 
known that magnesium deficiency can cause significant muscle 
weakness in humans (22, 23), and as Caddell points out, “reduced 
muscle power is a major clinical finding in magnesium deficient 
children” (24). Dhingra and colleagues showed a direct correla-
tion between hypomagnesemia and respiratory muscle function 
in humans (25), and Stendig-Lindberg and colleagues demon-
strated that maximum isometric voluntary contraction force was 
significantly weaker in hypomagnesaemic subjects (26, 27). These 
and other recent studies (28) show that magnesium deficiency 
directly and significantly impacts muscle strength in general and 
respiratory muscle strength specifically. As Matias and colleagues 
explain, magnesium deficiency has a significant effect on muscle 
performance, probably due to the key role of magnesium in ener-
getic metabolism, transmembrane transport, muscle contraction, 
and on the cellular level on Na-K ATPase, Na–K–Cl co-transport, 
K channels, charge screening, and permeability effects on mem-
branes (29). In this context, it is important to note that in terms 
of contractile properties and fatigue, the diaphragm behaves like 
other skeletal muscles (30).
At least two studies show that SIDS victims and near-miss 
infants have abnormalities in muscle tone. In 1976, the results 
from a large study containing 1,553 infants and 12 unexpected 
deaths were published. The study used the Graham–Rosenblith 
Scales behavioral examination to measure muscle strength 
and co-ordination. Of the 12 likely SIDS cases, all but 1 had 
no unusual findings on muscle tonicity. The infants displayed 
marked head lag, poor tonicity, moderate trembling or shak-
ing, arching, and hyperactivity (31). The authors associated 
this with central nervous system involvement, but it is use-
ful to consider other possible explanations. As Flink notes, 
important symptoms of magnesium deficiency are “neuro-
muscular hyperactivity including tremor, myoclonic jerks 
[and] convulsions” (32). Similarly, Wong and Teh reported on 
13 cases of convulsions or tremors in children (aged 1  day 
to 14 months) with hypomagnesemia. The authors note that 
on recovery, either spontaneously or after administration of 
magnesium, serum magnesium returned to normal levels, 
and that it seems likely that hypomagnesemia caused the 
tremors or convulsions (33). Another SIDS study to consider 
in this context is the systematic neurologic examination of 
41 near-miss infants, 7 normal siblings of SIDS victims, and 
21 normal control infants conducted by the Sudden Death 
Research Project at Stanford University School of Medicine. 
The study found consistent abnormalities of muscle tone in 
the near-miss infants who were under 3 months of age (34). 
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The evidence discussed above helps put the municipal water/
magnesium studies in context and suggests that SIDS victims 
and near-miss infants have compromised muscle function 
(whether or not associated with hypomagnesemia). This 
fact by itself is significant in the context of the SIDS–CDF 
hypothesis.
Magnesium is a central element with multiple roles in human 
biology, and as Baaij and colleagues point out, “magnesium is 
an essential ion for health and it plays an important role in the 
physiological function of the brain, heart, and skeletal muscles” 
(35). In light of the existing evidence, it would be presumptuous 
to discuss its potential role in SIDS but tentatively. Still, the two 
population-level studies and the clinical results from SIDS and 
near-miss infants provide intriguing data on the potential role 
of magnesium and muscle weakness in the etiology of SIDS. The 
critical role of magnesium in muscle function is well established, 
and compelling data suggest that SIDS victims have abnormal 
muscle tonicity. Combined with the existing evidence regarding 
the possible role of respiratory muscles in SIDS, it seems obvi-
ous that the role of the diaphragm in SIDS should be rigorously 
investigated.
Hyperthermia is the other factor that I would like to discuss 
in the context of the SIDS–CDF hypothesis. Dallas first sug-
gested that overheating might contribute to SIDS in 1974 but 
presented no evidence (36). Several authors have since argued 
that hyperthermia is significantly associated with SIDS (37–39). 
In 1984, Stanton reported that of the 34 SIDS victims: “19 
babies were unusually hot or sweating when found dead; 14 
died in an unusually warm environment; 17 had evidence of 
a terminal infective illness; and 24 were excessively clothed or 
overwrapped … In 6 of 15 babies (40%) whose rectal tempera-
ture was recorded after death, the temperature was above 37°C, 
the highest being 42°C” (40). In 1990, Fleming and colleagues 
reported that, “overheating and the prone position are indepen-
dently associated with an increased risk of sudden unexpected 
infant death, particularly in infants aged more than 70  days” 
(41), and The Lancet published an editorial titled Prone, Hot 
and Dead that discussed link between hyperthermia and SIDS 
the same year. The editors note the pathological findings are 
non-specific and that no mode of action has been established. 
Interestingly, they also highlight that researchers have observed 
that: “environmental temperature of healthy infants increased 
respiratory movement, a finding that suggests an effect on the 
respiratory control system.” The editorial suggests that a possible 
mechanism is: “[hyperthermia] together with an additional fac-
tor—for example, a viral infection—is the stimulus for a further 
increase in metabolic rate, with subsequent loss of respiratory 
control. This view accords with several other observations that 
symptoms of illness, especially of respiratory infection, are 
present in many infants who die from SIDS.” (42).
However, while there is robust evidence linking hyperthermia 
to SIDS, no causal mechanism has been established. The elevated 
temperatures observed in SIDS victims are regularly observed in 
infants who do not succumb to the syndrome, and importantly, 
many SIDS victims show no evidence of hyperthermia. Recent 
research found no significant expression of heat-shock proteins 
(HSP27 and HSP70), thereby suggesting that hyperthermia is not 
a primary causal factor in SIDS (43). As with many SIDS risk 
factors, hyperthermia is a paradox. There is compelling epide-
miological and population data to suggest that at least in some 
cases, hyperthermia is a significant risk factor for SIDS, but at 
the same time, it is highly unlikely that hyperthermia is the cause 
of SIDS.
To explain this paradox, it is useful to recall the observation 
by The Lancet editors regarding how higher environmental 
temperature increases the respiratory movement in healthy 
infants. Indeed, it has been known since 1905 that hyperthermia 
increases the ventilatory workload (44). More recently, Maskrey 
observed that: “high body temperature causes an increased ven-
tilation (chiefly through increased frequency of breathing) via a 
descending drive from thermoreceptors and thermoregulatory 
integrating centers in the hypothalamus” (45). In a comprehensive 
recent review, Tsuji and colleagues again show that hyperthermia 
can induce hyperventilation in humans (46). The authors point 
out that: “during passive heating at rest, elevation of body core 
temperature leads to increased ventilation independently of 
metabolic factors, resulting in a reduction of arterial CO2 pres-
sure (hypercapnia).” The critical threshold for the initiation of 
hyperventilation for passive heating at rest is when body core 
temperature reaches a critical threshold of ~38.5°C. As discussed 
in the beginning of this review, the SIDS–CDF hypothesis argues 
that any factor that either increases the respiratory workload or 
decreases the force generating capacity of the respiratory muscles 
can contribute to SIDS. Hyperthermia is known to increase the 
respiratory workload, and combined with other factors such as 
non-lethal infections and the prone sleeping position, it could, 
in some circumstances, push the diaphragm over its endurance 
threshold.
I have reviewed evidence suggesting that magnesium defi-
ciency and hyperthermia are contributing, but not causal, factors 
in SIDS, and that by themselves, neither magnesium deficiency 
nor hyperthermia lead to CDF. As noted earlier, both magnesium 
deficiency and hyperthermia affect multiple physiological func-
tions, and we must be cautious in drawing conclusions about their 
role in SIDS. Suffice it to say that the SIDS–CDF hypothesis offers 
a parsimonious causal mechanism for the large body of data on 
magnesium deficiency, hyperthermia, and SIDS.
A central challenge of SIDS research is that is it very difficult 
to design experiments that mimic the syndrome. The underlying 
reason is that experiments by their very nature seek to isolate 
variables and SIDS is multifactorial. No single factor is “the 
cause” of SIDS, but many factors can contribute to respiratory 
muscle failure, often in different configurations. We know that 
severe respiratory muscle weakness can lead to death in adults; it 
remains to be determined if SIDS victims succumb to respiratory 
muscle weakness. To test the SIDS–CDF hypothesis, experiments 
should focus on the diaphragm and its vulnerabilities, and we 
should seek to develop experimental protocols to determine if 
induced and progressive respiratory muscle weakness in experi-
mental animals replicates the pathophysical outcomes of SIDS. 
We should also seek identify possible molecular markers from the 
diaphragms of adults who have died of respiratory muscle failure 
and should actively leverage the extensive research by Supinski 
and Callahan into the molecular pathways of infection induced 
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respiratory muscle weakness (47, 48). The respiratory pump is as 
vital as the heart, but very little experimental research has been 
conducted on the possible role of the diaphragm in SIDS. The 
purpose of this article has been, in part, to inspire that research.
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